Scan Me!
SAN DIEGO — Bexagliflozin was effective and well-tolerated in lowering hemoglobin A1c in patients with diabetes and stage 3a/3b CKD, according to study results presented at ASN Kidney Week. We have fewer and fewer oral agents to use, despite the fact that diabetes is obviously a leading cause of chronic kidney disease,” Andrew S. Allegretti, MD, of Massachusetts General Hospital,
Source: Bexaglifozin demonstrates efficacy in lowering HbA1c in patients with diabetes and stage 3a/3b CKD
New to Writers Site?
If so, you might be puzzled. The purpose of the Writers site is to provide dietitians in every niche with an opportunity to promote their independent businesses through Writing Articles within their specialty.
You Have Reached an Article Request Page: By publishing articles on NutriScape.NET, Dietitians can link to their own website or social media pages through the biography. We believe in Crowdsourcing. When RD/RDNs band together through The NutriScape Project, we can build a better future for all of us!
How to Use These Article Ideas
Labs
Supplements
Log in
Register
